Australia Grapples with Decades-Worst Diphtheria Outbreak; Vaccination Urged

Australia is currently experiencing its most severe diphtheria outbreak in decades, with health officials expressing significant concern as the highly contagious bacterial infection spreads across multiple states and territories. As of May 20, 2026, a total of 223 confirmed diphtheria cases have been recorded across the Northern Territory, Western Australia, Queensland, and South Australia, with the Northern Territory and Western Australia being the most affected regions. This surge represents an unprecedented epidemic, far exceeding the average number of cases seen nationally over the past five years. The outbreak reportedly began in late 2025 in remote Aboriginal communities in the Northern Territory and has since escalated into a multi-state public health emergency. There is also a suspected diphtheria-related death under investigation in the Northern Territory, which, if confirmed, would be Australia's first fatality from the disease since 2018. Federal Health Minister Mark Butler described the situation as "very concerned" and "probably the biggest diphtheria outbreak we've seen, certainly for decades." The Australian Medical Association (AMA) has urgently called on families across the country to ensure they are fully vaccinated against diphtheria, emphasizing that a decline in vaccination rates allows dangerous diseases, once nearly eradicated, to resurface. Experts attribute the resurgence partly to falling childhood vaccination rates nationally. Australia's childhood vaccination coverage at 24 months fell below 90 percent in 2024 for the first time since 2016. By the end of 2025, only 79.7 percent of babies received their diphtheria vaccine doses on schedule, almost doubling the number of unvaccinated or late-vaccinated children compared to early 2020 figures. Globally, the COVID-19 pandemic significantly impacted routine immunization services and surveillance activities, contributing to a rise in diphtheria outbreaks in various regions. Diphtheria is a serious infection caused by strains of *Corynebacterium diphtheriae* bacteria that produce a toxin. It typically affects the respiratory system or the skin. Respiratory diphtheria can lead to severe, painful swelling of the throat and neck, potentially blocking the airway and causing breathing difficulties. A hallmark sign is a thick, grayish material covering the back of the throat. Cutaneous diphtheria, or skin infection, results in ulcers and local swelling. The current Australian outbreak primarily features cutaneous infections, accounting for over 80% of cases, though respiratory diphtheria cases are also present and considered more dangerous. Treatment for diphtheria includes antibiotics, such as penicillin or erythromycin, to kill the bacteria and prevent its spread, and an antitoxin to neutralize the bacterial toxin circulating in the body. Early and aggressive treatment is crucial, as the risk of complications or death decreases considerably with prompt intervention. Patients are typically isolated to prevent further spread of the infection. Vaccination remains the most effective preventive measure against diphtheria. The World Health Organization (WHO) recommends a three-dose primary vaccination series followed by three booster doses, starting as early as six weeks of age. In Australia, authorities now recommend booster shots every five years for at-risk adults, a reduction from the previous 10-year interval, due to waning immunity. The WHO also released its first-ever comprehensive clinical management guidelines for diphtheria in February 2024, responding to increasing outbreaks globally and a worldwide shortage of diphtheria antitoxin (DAT). For an Indian audience, this news from Australia serves as a critical reminder of the importance of maintaining high vaccination coverage. Diphtheria is not unknown in India; the DTP vaccine was introduced in 1978, significantly reducing incidence in pediatric populations but shifting infections to older age groups. Studies indicate a definite need for Tetanus and Diphtheria (Td) vaccination in adult Indian populations who may have missed primary immunizations. India's National Technical Advisory Group on Immunization (NTAGI) has recommended replacing the Tetanus Toxoid (TT) vaccine with the Td vaccine for all age groups, including pregnant women, to boost diphtheria immunity. Moreover, recent diphtheria crises in India, such as in Rajasthan in 2025, have highlighted the impact of vaccine hesitancy and the critical role of rapid response and vaccination efforts in saving lives. The Australian situation underscores the universal vulnerability to vaccine-preventable diseases when immunity gaps emerge, reinforcing the ongoing global public health challenge diphtheria poses, even in developed nations. This outbreak also brings to light systemic issues, including overcrowded housing and gaps in infectious disease surveillance, especially impacting vulnerable communities, such as Indigenous Australians in the current context. Collaborative efforts with Aboriginal-controlled health organizations are underway to increase vaccination rates and address these underlying health disparities. The continuous spread across state borders, genomically linked cases, and the high proportion of cutaneous infections make this outbreak particularly challenging from a public health perspective, emphasizing the need for sustained vigilance and robust immunization programs worldwide.

Frequently Asked Questions

Read Full Story on Quick Digest